Case 1
The 'rabbit syndrome' was first observed in its typical form in a 66-year old female who was receiving a piperazine phenothiazine (perphenazine, 8 mg T.LD.). The tremor of the lips, of the orbicularis oris and of the inferior maxilla was very rapid, very pronounced and arhythmic. Her facies was almost expressionless and the eye blinking rare. When she attempted to talk, these abnormal movements became even more accentuated and rapid. Only the muscles of the inferior part of the face were involved; particularly the superficial muscles of the mouth and the masseters. There was no lateral displacement of the inferior mandibula.
Her rabbit-like movements having decreased transitorily when given benztropine mesylate intravenously (2 mg), an oral antiparkinsonian agent (trihexyphenidyl, 2 mg T.I.D. and 1 mg h.s., replaced later by procyclidine chlorhydrate -2.5 mg Q.I.D.) was added to her reduced neuroleptic medication (perphenazine 4 mg T.I.D. and chlorpromazine 100 mg h.s.), resulting in the disappearance of her abnormal movements (21) . A little over a year later her antiparkinsonian agent was withdrawn and her abnormal perioral movements resumed rapidly, although with less intensity, and they subsided again upon resumption of her antiparkinsonian drug.
On her first admission in 1951 her psychiatric condition was believed to be post-encephalitic sequella. In 1954 a diagnosis of postencephalitic psychosis was made but was changed to paranoid schizophrenia during her last hospitalization. In 1951 a trepanation had been performed on the right lateral anterior region of the skull because a tumoral process had been suspected. A pneumoencephalogram, done in 1951, was negative but at the end of 1967, before she presented her striking rabbitlike movements of the mouth, some degree of cortical atrophia was detected. Her electroencephalogram had been either borderline or slightly abnormal since 1951. In 1952 the electroencephalographic alterations had been indicative of an irritative atrophic lesion.
Case 11
The second patient, a 67 year-old female, hospitalized for close to forty years, presented choreo-athetotic movements, as well as a marked bucco-Iinguo-mandibular dyskinesia related to her neuroleptic treatment (21) . The onset of her choreo-athetotic movements seems to have occurred in 1960 when she was receiving a combination of neuroleptics (trifluoperazine 12 mg daily and chlorpromazine 25 mg daily). Her bucco-linguo-mandibular dyskinesia was first reported in 1968. During that period she had received a neuroleptic and antiparkinsonian medication (trifluoperazine, 5 mg T.I.D. and benztropine mesylate, 2 mg B.ID.).
In subsequent attempts to find a treatment for the neuroleptic-induced permanent-like dyskinesias, her medication (thioridazine, 50 mg T.LD. and benztropine mesylate, 2 mg B.I.D.) was discontinued and she received only a low dose of reserpine (0.75 mg -1.0 mg daily) which did not induce any extrapyramidal side effects (8, 9) . With this treatment her neurologic symptoms practically disappeared, but resumed rapidly upon discontinuance of reserpine and the reinstatement of her former medication at half the dosage. Two months later it was increased to its initial dose and another neuroleptic had to be added (trifluoperazine, 2 mg T.I.D.).
Owing to the recurrence of her neurologic symptoms and to the dramatic improvement formerly obtained with reserpine, her neuroleptic and antiparkinsonian medication was withdrawn once more and reserpine readministered. From a neurologic viewpoint, the palmo-mental and labio-oral-reflexes could still be provoked but some parkinsonian symptoms were present. Eight days after resumption of this treatment she presented a transitory episode (three days), during which mild rabbitlike movements of the mouth could be observed (reserpine, 0.75 daily). Her permanentlike dyskinesias and her mental condition continued to improve with daily administration of reserpine (0.50 mg -0.75 mg).
Case III
The third patient, a 54 year-old female, showed rabbit-like movements of a moderate intensity, which had the peculiarity of being localized mostly to the right side of the mouth. In addition to some parkinsonian signs, the labio-oral reflex could be elicited and increased the intesity of her abnormal movements. In 1970, during her third hospitalization since 1967, a nurse noticed some abnormal movements of her mouth. At the time she was receiving only chlorpromazine (50 mg) at bedtime. During the last part of her second hospitalization in 1969, she had been receiving a combination of neuroleptics (trifluoperazine, 5 mg Q.I.D. and thioridazine, 50 mg h.s.) and was released from hospital with these psychotropic drugs. However, the movements of the mouth seemed to have increased a few days after the administration of a long-acting neuroleptic (25 mg of fluphenazine enanthate LM.).
Her dosage of procyclidine chlorhydrate was progressively augmented (5 mg Q.I.D.), controlling these abnormal movements fairly well, but when she was tired they recurred transitorily.
Her anamnesis indicated that she had had seizures from three months of age until she was eight. When three years old she received a head trauma, and at the age of twenty-four she suffered from some unspecified transitory impairment of the limbs. She also suffered aphasia for two days when 27, and had been treated as having petit mal epilepsy at the age of 35; but all this was not well documented. In 1966 her electroencephalogram had shown some theta dysrhythmia.
Case IV
When first seen this 66 year-old male patient did not show any spontaneous dyskinetic rabbit-like movements of the lips. They were elicited by asking him to follow with a pen a drawn labyrinth pattern. The palmo-mental and labia-oral reflexes could be provoked and were triggering the movements of the lips. There were also parkinsonian symptoms. The current hospitalization was his second since 1964. Nearly two years before his examination here a nurse had recorded that he presented some abnormal movements of the mouth. At the time the patient was receiving trifluoperazine (5 mg B.I.D.), methotrimipramine (125 mg daily) and an antiparkinsonian (benztropine mesylate, 2 mg B.LD.).
When first examined here at the end of 1969 this medication was stopped, and within three months his abnormal movements evolved toward a typical permanent-like bucco-lingual syndrome, with slight rapid protrusion of the tongue and sucking-like movements of the lips. Trihexyphenidyl given for two weeks exerted no therapeutic effect. The intensity of the bucco-lingual syndrome seemed to decrease very slightly with administration of a-methyldopa but, as time went on and without neuroleptic therapy, his mental condition worsened and he became unco-operative and all efforts to persuade him to continue being examined regularly were in vain.
Case V
A 47 year-old male, hospitalized for the second time since 1967, showed a spontaneous tremor (of mild intensity) of the inferior lip. When the patient swallowed or closed his mouth the dyskinetic movement ceased, reappearing when the inferior mandibula was relaxed and at rest. When he was asked to follow with a pen a drawn labyrinth pattern, the abnormal movements became intense, more rapid and more resembling those of a rabbit's mouth. The palmo-mental and labio-oral reflexes could SS-71 be provoked, increasing thus the rabbit-like movements. Some parkinsonian signs were also present. The intravenous administration of benztropine mesylate (2 mg) could stop the dyskinetic movements in fifteen minutes.
In 1968, when the patient was receiving thioproperazine (10 mg T.I.D.), plus a bedtime medication (chlorpromazine, 50 mg and promethazine, 50 mg) and an antiparkinsonian (benztropine mesylate 1 mg daily), a nurse recorded the presence of a tremor of the inferior lip. Subsequently, the patient received perphenazine, and when first examined here he was taking thioridazine alone (100 mg T.LD.). An antiparkinsonian agent (procyclidine chlorhydrate, 5 mg Q.I.D.) successfully controlled the abnormal movements of his lips, which reappear only intermittently when he is anxious or tired.
Conclusion
Five cases of an unusual extrapyramidal reaction labeled 'rabbit syndrome' have been presented. As in the case of the oral permanent-like dyskinesias, these rabbitlike movements can be intensified by asking patients to follow a labyrinth pattern with a pencil (18, 19, 21) and are also augmented by anxiety and fatigue. However, contrary to the former type of oral dyskinesias, where various degrees of improvement can be obtained with reserpine but more so with a-methyldopa (18, 19, 21, 22) , the latter type appears to respond to the administration of antiparkinsonian agents. Therefore, this differential response suggests a different underlying biochemical mechanism, most likely a differential imbalance in the neurotransmitters involved in the normal functioning of the extrapyramidal system. Some additional evidence in favour of this hypothesis is constituted by the fact that in one case this syndrome occurred transitorily in a patient resuming reserpine therapy for her permanent-like dyskinesias, while in another patient the 'rabbit syndrome' evolved toward a typical permanent-like bucco-lingual dyskinesia.
Subtle brain lesions may also be implied in both types of dyskinetic phenomena, as is indicated by the presence of 'release reflexes' (palma-mental and labio-oral reflexes) which are indeed considered by some to be a sign of brain damage. Moreover, the relationship between nervous structures and brain amines involved in these conditions still remains unclear. Cell degeneration was found in the substantia nigra and gliosis in the midbrain and brain stem of patients suffering from bucco-linguo-mandibular dyskinesia, leading to the suggestion that the lesion of the substantia nigra, in combination with other lesions, may be the cause of dyskinesia (4). In monkeys, electrolytic lesions located along the dorsomedial edge of the substantia nigra have been shown to be associated with cell loss in this structure and with a marked depletion of dopamine in both divisions of the ipsilateral striatum, accompanied by hypokinesia of the contralateral limbs (14) . In Parkinson's disease a deficiency in the dopamine level of the striatum is assumed to play an important role, and many clinical studies using L-DOPA in the treatment of this disorder are under way (2,$,23) . Yet the administration of L-DOPA induces neurological side effects in cases resembling the dyskinesias of the permanent type, in particular of the bucco-linguo-mandibular type (2, 5) . Depending upon the experimental conditions, 5-hydroxytryptophan (5-HTP) and serotonin can create gnawing movements in rats but these would be of a different type from those provoked by DOPA (7, 9) . In animals apomorphine as well as amphetamine can also trigger such movements (7, 10) . It is interesting that amphetamine has been reported to induce dyskinetic movements of the mouth and tongue in man (8, 11, 12) . The stereotyped behaviour caused by L-DOPA in rats has been assumed to be in relation to an increased cerebral level of dopamine and an acceleration of its turnover, whereas the one induced by amphetamine would coincide with an increase of o-methylated dopamine (10) .
At the present moment no causal relationship can be established with any particular neuroleptic, but some link can be suspected to exist with the more potent ones such as the piperazine phenothiazine derivates. As the patients in this study have received various types of neuroleptics the dyskinetic phenomena described can be only coincident with the use of potent neuroleptics given in an attempt to control their psychiatric symptomatology more effectively.
